Procurement of Vaccines
SuljettuAlkuperäinen tarjouskilpailun kuvaus
Suorita riskianalyysi
Tunnista mahdolliset riskit, epäjohdonmukaisuudet ja varoitusmerkit kaikista tarjousasiakirjoista. Saat yksityiskohtaisen riskiraportin, jossa on vakavuustasot ja lievennyssuositukset.
Kirjaudu sisäänVoittostrategia
Hanki tekoälyllä luotu voittostrategia, joka on räätälöity tähän tarjouskilpailuun. Sisältää voiton todennäköisyyspisteet, keskeiset mahdollisuudet ja haasteet, suositellut tarjouksen painopistealueet, kilpailuasemanäkemykset ja toimintasuositukset mahdollisuuksiesi maksimoimiseksi.
Kirjaudu sisäänKilpailijat
Päivitä nähdäksesi, mitkä yritykset todennäköisesti tekevät tarjouksen tästä hankinnasta, perustuen historialliseen hankintadataan.
Kirjaudu sisäänVaatimukset ja pätevyydet
17 vaatimusta 5 kategoriassa
Vaatimusten esikatselu
Rekisteröidy nähdäksesi täydelliset vaatimukset ja analyysin
Asiakirjat
17 asiakirjaa saatavilla AI-yhteenvedoilla
This document contains the requirements for Part 10 (Hepatitis A vaccine for adults) of a vaccine procurement, outlining exclusion and selection criteria, technical and financial offer requirements, and the evaluation criteria based on the lowest price without VAT.
This document outlines the specific requirements for Part 11 (Hepatitis A vaccine for children) of the 'Vaccine Procurement' tender, detailing exclusion and selection criteria, technical and financial proposal requirements, and evaluation criteria for bidders.
This document contains detailed procurement requirements for Part 1 (anti-tick vaccine for adults), outlining exclusion and selection criteria, technical and financial proposal specifications, mandatory submission documents, and evaluation criteria based on the lowest price.
This document outlines the requirements for Part 12 (A+B hepatitis vaccine for adults) of a vaccine procurement tender, detailing exclusion and selection criteria, technical and financial proposal requirements, and evaluation criteria based on the lowest price without VAT.
This document contains the specific requirements and evaluation criteria for Part 2 (anti-tick vaccine for children) of a vaccine procurement tender by Rīgas veselības centrs, detailing the application, declarations, licenses, technical and financial proposals, and other necessary documents bidders must submit.
This document details the mandatory requirements for bidders, including exclusion and selection criteria, technical and financial proposal specifications, and evaluation criteria for the procurement of pneumococcal vaccines for adults.
This document outlines the requirements for Part 4 (Pneumococcal infection vaccines) of the "Rīgas veselības centrs" SIA procurement, detailing exclusion and selection criteria, technical and financial proposal requirements, and evaluation criteria based on the lowest price.
This document contains the detailed procurement requirements for Part 5 (Human papillomavirus vaccine) of the vaccine acquisition, outlining exclusion and selection criteria, technical and financial offer requirements, and the lowest price evaluation method.
This document contains detailed requirements for submitting an offer for the procurement of rotavirus vaccines (Part 6), including exclusion conditions, selection criteria, technical and financial proposal specifications, and evaluation criteria based on the lowest price without VAT.
This document contains the procurement requirements for Part 7 (Chickenpox vaccine) of the vaccine acquisition tender, outlining mandatory submission documents, technical and financial offer specifications, and evaluation criteria based on the lowest price without VAT.
This document details the requirements for Part 8 of a vaccine procurement tender, including exclusion and selection criteria, technical and financial proposal specifications, and evaluation criteria based on the lowest price.
This document outlines the specific requirements for Part 9 (Hepatitis B vaccine for adults) of a vaccine procurement tender, detailing exclusion and selection criteria, technical and financial offer requirements, and evaluation criteria based on the lowest price without VAT.
This document contains an application form for bidders to participate in an open competition for vaccine procurement, requiring declarations of compliance with tender terms, pricing commitments, and various other affirmations.
This document contains a certification form for bidders to confirm that their offer was developed independently without collusion with competitors, and to declare any permitted communications.
This document contains a technical and financial offer template for the procurement of various vaccines, detailing quality requirements, estimated quantities, and fields for bidders to provide manufacturer information, unit prices, and total sums.
This document contains a draft contract for the procurement of vaccines for the Riga Health Center, outlining the terms for supply, payment, quality, and responsibilities between the client and the supplier.
This document contains the regulations for an open competition organized by SIA “Rīgas veselības centrs” for the procurement of vaccines, detailing general information, submission requirements, and terms for bidders.
Asiakirjojen esikatselu
Rekisteröidy nähdäksesi asiakirjojen yhteenvedot ja analyysin
Hankinnan laatupisteet
This tender for vaccine procurement presents a detailed structure with clear requirements and an open procedure. However, it is significantly undermined by an unrealistic estimated value of 0.01 EUR and reported restricted document access, raising serious concerns about fairness and practical execution.
Pisteiden erittely
The tender generally complies with legal requirements, featuring a clear open procedure, reasonable submission period, and correct CPV codes. No disputes are reported. However, the 'Restricted document access' flag is a significant concern, potentially hindering transparency and equal treatment, thus lowering the score.
The tender description is clear, and AI-extracted requirements are well-categorized and detailed. Evaluation criteria (lowest price) are specified, and performance conditions are clearly referenced to specific documents. The overall structure appears well-documented.
All basic information, financial details (though problematic), timeline, and location are provided. A comprehensive list of 18 documents with summaries is available. However, the 'Restricted document access' flag, if true, compromises the practical completeness for bidders, and the unrealistic estimated value makes the financial aspect incomplete in a practical sense.
Fairness is severely impacted by the 'Estimated Value: 0.01 EUR', which is highly unrealistic for vaccine procurement and misleading to potential bidders. Coupled with the 'Restricted document access' flag, these issues fundamentally undermine transparency and equal opportunity. While evaluation criteria are objective, these critical flaws lead to a low score.
The tender lists 'E-Procurement' and specifies a contract duration. However, the 0.01 EUR estimated value makes financial planning and bid preparation highly impractical. The reported 'Restricted document access' also presents a significant practical barrier for bidders. The contradiction regarding e-submission adds confusion.
While most key fields are populated and dates are logical, the 'Estimated Value: 0.01 EUR' is a glaring inconsistency for vaccine procurement. Other contradictions, such as 'E-Procurement' being listed but 'No e-submission' flagged, and 'Restricted document access' despite 18 document summaries, indicate data consistency issues.
The tender does not include any explicit green procurement, social aspects, or innovation focus. It is also not indicated as EU funded, which often correlates with higher sustainability standards.
Vahvuudet
Huolenaiheet
Suositukset
Tekoälyn pisteytyksen esikatselu
Rekisteröidy nähdäksesi täydelliset vaatimukset ja analyysin
Luottokorttia ei vaadita • Asennus 2 minuutissa
AI-avustaja
Hei! Olen tekoälyavustajasi tässä hankinnassa. Voin auttaa sinua ymmärtämään vaatimuksia, määräaikoja, kelpoisuuskriteerejä ja tarjoamaan strategisia oivalluksia.
Luottokorttia ei vaadita